CIPLA LTD vs THYROCARE TECH LTD
A side-by-side comparison of CIPLA LTD (CIPLA) and THYROCARE TECH LTD (THYROCARE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
CIPLA LTD and THYROCARE TECH LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 131%"]
- − ["Stock is trading at 14.0 times its book value", "Promoters have pledged 100% of their holding.", "Promoter holding has decreased over last 3 years: -10.2%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.